(Reuters) -New Zealand’s Synlait Milk reported a narrower annual net loss on Monday, aided by strong customer demand, while announcing the sale of its North Island assets for NZ$307 million ($177.20 million) to U.S.-based Abbott Laboratories.
…
Synlait trims annual loss, inks $177 million deal to sell North Island assets
